Publications

Bicalutamide (Casodex) 150 Mg plus Standard Care in Early Non-Metastatic Prostate Cancer: Results from Early Prostate Cancer Trial 24 at a Median 7 Years' Follow-Up

AuthID
P-004-BNY

Author(s)

Wirth, M

Tyrrell, C

Delaere, K

Sanchez Chapado, M

Ramon, J

Wallace, DMA

Hetherington, J

Pina, F

Heyns, CF

Navani, S

Armstrong, J

Group Author(s)

CASODEX Early Prostate Canc Triali

Document Type

Article

Year published

2007

Published

in PROSTATE CANCER AND PROSTATIC DISEASES, ISSN: 1365-7852

Volume: 10, Issue: 1, Pages: 87-93 (7)

Indexing

Wos^®

Scopus^®

Crossref^®

Pubmed^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1038/sj.pcan.4500916

Pubmed: 17102802

Scopus: 2-s2.0-33847609549

Wos: WOS:000244604800013

Source Identifiers

ISSN: 1365-7852

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

Bicalutamide (Casodex) 150 Mg plus Standard Care in Early Non-Metastatic Prostate Cancer: Results from Early Prostate Cancer Trial 24 at a Median 7 Years' Follow-Up

Useful Links

Get Help

Federated Authentication (Click on the image)

Bicalutamide (Casodex) 150 Mg plus Standard Care in Early Non-Metastatic Prostate Cancer: Results from Early Prostate Cancer Trial 24 at a Median 7 Years' Follow-Up

Useful Links

Get Help